论文部分内容阅读
目的分析布地奈德联合异丙托溴铵治疗小儿毛细支气管炎的临床疗效。方法选取2013年4月至2014年4月收治的小儿毛细支气管炎患儿92例,按治疗方法的不同,分为对照组(46例)和观察组(46例),两组患儿均给予常规治疗,对照组在此基础上雾化吸入异丙托溴胺治疗,观察组在常规治疗基础上雾化吸入布地奈德联合异丙托溴胺治疗,治疗1周后,对比两组患者的临床效果及临床症状消失时间。结果观察组喘息缓解时间、咳嗽消失时间、肺部哮鸣音消失时间及住院时间均较对照组短,差异有统计学意义(P<0.05);观察组有效率为95.65%,对照组有效率为78.26%,差异有统计学意义(P<0.05)。结论小儿毛细支气管炎采取布地奈德联合异丙托溴胺雾化吸入治疗的临床效果显著,能有效缓解患儿的临床症状,缩短住院时间。
Objective To analyze the clinical efficacy of budesonide combined with ipratropium bromide in the treatment of pediatric bronchiolitis. Methods Ninety-two children with bronchiolitis admitted from April 2013 to April 2014 were divided into control group (46 cases) and observation group (46 cases) according to the different treatment methods, both groups were given On the basis of conventional treatment, the control group inhaled ipratropium bromide treatment, the observation group was treated with atomization inhalation of budesonide and ipratropium bromide on the basis of routine treatment. After one week of treatment, the patients in both groups were compared Clinical effect and clinical symptoms disappear time. Results The observation group had shorter remission time, longer cough disappearance time, shorter duration of lung wheeze sound and shorter hospital stay than those in the control group (P <0.05). The effective rate in the observation group was 95.65% 78.26%, the difference was statistically significant (P <0.05). Conclusions Pediatric bronchiolitis with budesonide combined with ipratropium bromide inhalation therapy has a significant clinical effect, which can effectively relieve the clinical symptoms of children and shorten the hospital stay.